4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-19-049117
President & CEO bought 5,000 shares at $43.63 ($218,150)
From the SEC's structured data for this filing
Trades in this filing
KAKKIS EMIL D · President & CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-09-11 | Purchase : show line 1 in the form | +5,000 | $43.63 | $218,150 | 472,479 | D |
| Open-market purchases · 5,000 sh · avg $43.63 · $218,150 | ||||||
Loading xslF345X03/doc4.xml…